ACADIA Pharmaceuticals
Stock Forecast, Prediction & Price Target
ACADIA Pharmaceuticals Financial Estimates
ACADIA Pharmaceuticals Revenue Estimates
ACADIA Pharmaceuticals EBITDA Estimates
ACADIA Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $484.14M N/A | $517.23M 6.83% | $726.43M 40.44% | Avg: $1.07B Low: $1.04B High: $1.11B avg. 47.45% | Avg: $1.20B Low: $1.16B High: $1.27B avg. 12.91% | Avg: $1.36B Low: $1.31B High: $1.43B avg. 12.69% | Avg: $1.50B Low: $1.44B High: $1.58B avg. 10.13% |
Net Income
% change YoY
| $-167.87M N/A | $-215.97M -28.65% | $-61.28M 71.62% | Avg: $208.73M Low: $85.18M High: $348.93M avg. 440.58% | Avg: $304.64M Low: $78.63M High: $489.81M avg. 45.94% | Avg: $360.40M Low: $342.93M High: $386.05M avg. 18.30% | Avg: $424.14M Low: $403.58M High: $454.33M avg. 17.68% |
EBITDA
% change YoY
| $-170.43M N/A | $-223.59M -31.18% | $-67.82M 69.66% | Avg: $-482.79M Low: $-501.18M High: $-468.99M avg. -611.80% | Avg: $-545.16M Low: $-575.01M High: $-524.83M avg. -12.91% | Avg: $-614.38M Low: $-648.02M High: $-591.47M avg. -12.69% | Avg: $-676.65M Low: $-713.70M High: $-651.42M avg. -10.13% |
EPS
% change YoY
| -$1.05 N/A | -$1.34 -27.61% | -$0.37 72.38% | Avg: $1.13 Low: $0.52 High: $2.13 avg. 404.23% | Avg: $1.59 Low: $0.48 High: $2.99 avg. 40.97% | Avg: $2.2 Low: $2.09 High: $2.36 avg. 38.63% | Avg: $2.59 Low: $2.46 High: $2.77 avg. 17.68% |
Operating Expenses
% change YoY
| $635.44M N/A | $730.66M 14.98% | $754.08M 3.20% | Avg: $841.04M Low: $817.01M High: $873.08M avg. 11.53% | Avg: $949.70M Low: $914.29M High: $1.00B avg. 12.91% | Avg: $1.07B Low: $1.03B High: $1.12B avg. 12.69% | Avg: $1.17B Low: $1.13B High: $1.24B avg. 10.13% |
FAQ
What is ACADIA Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 130.63% in 2025-2028.
We have gathered data from 15 analysts. Their low estimate is 85.18M, average is 208.73M and high is 348.93M.
What is ACADIA Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 20.80% in 2025-2028.
We have gathered data from 15 analysts. Their low revenue estimate is $1.04B, average is $1.07B and high is $1.11B.
What is ACADIA Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 125.38% in 2025-2028.
We have gathered data from 15 analysts. Their low earnings per share estimate is $0.52, average is $1.13 and high is $2.13.
What is the best performing analyst?
In the last twelve months analysts have been covering ACADIA Pharmaceuticals stock. The most successful analyst is Keith Tapper.